Literature DB >> 9671677

DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study.

M Ernst1, A J Zametkin, J A Matochik, P H Jons, R M Cohen.   

Abstract

Converging evidence implicates the dopaminergic system and the prefrontal and nigrostriatal regions in the pathophysiology of attention deficit hyperactivity disorder (ADHD). Using positron emission tomography (PET) with [fluorine-18]fluorodopa (F18-DOPA), we compared the integrity of the presynaptic dopaminergic function between 17 ADHD adults and 23 healthy controls. The ratio of the isotope concentration of specific regions to that of nonspecific regions reflects DOPA decarboxylase activity and dopamine storage processes. Of three composite regions (prefrontal cortex, striatum, and midbrain), only the prefrontal cortex showed significantly different F18-DOPA ratios in ADHD as compared with control adults (p < 0.01). The medial and left prefrontal areas were the most altered (lower F18-DOPA ratios by 52 and 51% in ADHD as compared with controls). Similarly, the interaction [sex x diagnosis] was significant only in the prefrontal cortex (p < 0.02): lower ratios in men than in women in ADHD and vice versa in controls. These findings suggest that a prefrontal dopaminergic dysfunction mediates ADHD symptoms in adults and that gender influences this abnormality. On the basis of previous neuroimaging findings in ADHD showing discrepant findings in adults and adolescents and on evidence for midbrain dopaminergic defect in adolescents, we hypothesize that the prefrontal dopaminergic abnormality in ADHD adults is secondary and results from an interaction of the primary subcortical dopaminergic deficit with processes of neural maturation and neural adaptation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671677      PMCID: PMC6793062     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

Review 1.  A possible pathophysiologic substrate of attention deficit hyperactivity disorder.

Authors:  K M Heilman; K K Voeller; S E Nadeau
Journal:  J Child Neurol       Date:  1991       Impact factor: 1.987

2.  Delayed L-phenylalanine infusion allows for simultaneous kinetic analysis and improved evaluation of specific-to-nonspecific fluorine-18-dopa uptake in brain.

Authors:  D J Doudet; C A McLellan; T G Aigner; R J Wyatt; R M Cohen
Journal:  J Nucl Med       Date:  1992-07       Impact factor: 10.057

3.  Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism.

Authors:  M Gill; G Daly; S Heron; Z Hawi; M Fitzgerald
Journal:  Mol Psychiatry       Date:  1997-07       Impact factor: 15.992

4.  Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder.

Authors:  F X Castellanos; J N Giedd; W L Marsh; S D Hamburger; A C Vaituzis; D P Dickstein; S E Sarfatti; Y C Vauss; J W Snell; N Lange; D Kaysen; A L Krain; G F Ritchie; J C Rajapakse; J L Rapoport
Journal:  Arch Gen Psychiatry       Date:  1996-07

5.  Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder.

Authors:  G J LaHoste; J M Swanson; S B Wigal; C Glabe; T Wigal; N King; J L Kennedy
Journal:  Mol Psychiatry       Date:  1996-05       Impact factor: 15.992

Review 6.  Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.

Authors:  M V Solanto
Journal:  Behav Brain Res       Date:  1998-07       Impact factor: 3.332

Review 7.  Attention-deficit hyperactivity disorder in adults.

Authors:  L Bellak; R B Black
Journal:  Clin Ther       Date:  1992 Mar-Apr       Impact factor: 3.393

8.  Dopamine neurotoxicity in cortical neurons.

Authors:  S Alagarsamy; M Phillips; T Pappas; K M Johnson
Journal:  Drug Alcohol Depend       Date:  1997-11-25       Impact factor: 4.492

9.  Human brain dopamine receptors in children and aging adults.

Authors:  P Seeman; N H Bzowej; H C Guan; C Bergeron; L E Becker; G P Reynolds; E D Bird; P Riederer; K Jellinger; S Watanabe
Journal:  Synapse       Date:  1987       Impact factor: 2.562

10.  Effects of selective dopamine depletion in medial prefrontal cortex on basal and evoked extracellular dopamine in neostriatum.

Authors:  D King; J M Finlay
Journal:  Brain Res       Date:  1995-07-10       Impact factor: 3.252

View more
  64 in total

Review 1.  The role of neuromodulators in selective attention.

Authors:  Behrad Noudoost; Tirin Moore
Journal:  Trends Cogn Sci       Date:  2011-11-08       Impact factor: 20.229

2.  Striatal sensitivity during reward processing in attention-deficit/hyperactivity disorder.

Authors:  Yannis Paloyelis; Mitul A Mehta; Stephen V Faraone; Philip Asherson; Jonna Kuntsi
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-06-05       Impact factor: 8.829

3.  Preventative treatment in an animal model of ADHD: Behavioral and biochemical effects of methylphenidate and its interactions with ovarian hormones in female rats.

Authors:  Jodi L Lukkes; Nadja Freund; Britta S Thompson; Shirisha Meda; Susan L Andersen
Journal:  Eur Neuropsychopharmacol       Date:  2016-07-05       Impact factor: 4.600

Review 4.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

5.  Knockout of latrophilin-3 in Sprague-Dawley rats causes hyperactivity, hyper-reactivity, under-response to amphetamine, and disrupted dopamine markers.

Authors:  Samantha L Regan; Jillian R Hufgard; Emily M Pitzer; Chiho Sugimoto; Yueh-Chiang Hu; Michael T Williams; Charles V Vorhees
Journal:  Neurobiol Dis       Date:  2019-06-06       Impact factor: 5.996

Review 6.  Cognitive neuroscience of Attention Deficit Hyperactivity Disorder: current status and working hypotheses.

Authors:  Chandan J Vaidya; Melanie Stollstorff
Journal:  Dev Disabil Res Rev       Date:  2008

7.  ADHD familial loading and abnormal EEG alpha asymmetry in children with ADHD.

Authors:  T Sigi Hale; Susan L Smalley; Jeff Dang; Grant Hanada; James Macion; James T McCracken; James J McGough; Sandra K Loo
Journal:  J Psychiatr Res       Date:  2009-12-16       Impact factor: 4.791

8.  Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study.

Authors:  C J Vaidya; G Austin; G Kirkorian; H W Ridlehuber; J E Desmond; G H Glover; J D Gabrieli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  Cross-sectional evaluation of cognitive functioning in children, adolescents and young adults with ADHD.

Authors:  Ivo Marx; Thomas Hübner; Sabine C Herpertz; Christoph Berger; Erik Reuter; Tilo Kircher; Beate Herpertz-Dahlmann; Kerstin Konrad
Journal:  J Neural Transm (Vienna)       Date:  2009-12-02       Impact factor: 3.575

10.  European clinical guidelines for hyperkinetic disorder -- first upgrade.

Authors:  Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.